Fulminant type 1 diabetes-an important subtype in East Asia-Reference-Cited by-同舟云学术

Fulminant type 1 diabetes-an important subtype in East Asia

Published:2011-11 Issue:8 Volume:27 Page:959-964
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab. Res. Rev.

Author:

Imagawa Akihisa,Hanafusa Toshiaki

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference33 articles.

1. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group;Imagawa;N Engl J Med,2000

2. A proposal of three distinct subtypes of type 1 diabetes mellitus based on clinical and pathological evidence;Imagawa;Ann Med,2000

3. Fulminant type 1 diabetes: a nationwide survey in Japan;Imagawa;Diabetes Care,2003

4. Report of Japan Diabetes Society Committee on fulminant type 1 diabetes mellitus research: epidemiological and clinical analysis and proposal of diagnostic criteria;Hanafusa;J Japan Diab Soc,2005

5. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners;Hanafusa;Nat Clin Pract Endocrinol Metab,2007

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct changes to pancreatic volume rather than pancreatic autoantibody positivity: insights into immune checkpoint inhibitors induced diabetes mellitus;Diabetology & Metabolic Syndrome;2024-01-23

2. Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments;Biomedicine & Pharmacotherapy;2023-12

3. Fulminant type 1 diabetes: Focusing on triggering factors;Diabetes/Metabolism Research and Reviews;2023-10-10

4. Fulminant type 1 diabetes linked with fetal death in utero;BMJ Case Reports;2023-10

5. Recent advances in immune checkpoint inhibitor-induced type 1 diabetes mellitus;International Immunopharmacology;2023-09